A framework for fibrolamellar carcinoma research and clinical trials-Reference-Cited by-同舟云学术

A framework for fibrolamellar carcinoma research and clinical trials

Published:2022-02-21 Issue:5 Volume:19 Page:328-342
ISSN:1759-5045
Container-title:Nature Reviews Gastroenterology & Hepatology
language:en
Short-container-title:Nat Rev Gastroenterol Hepatol

Author:

Dinh Timothy A.,Utria Alan F.^ORCID,Barry Kevin C.,Ma Rosanna,Abou-Alfa Ghassan K.,Gordan John D.,Jaffee Elizabeth M.^ORCID,Scott John D.,Zucman-Rossi Jessica^ORCID,O’Neill Allison F.,Furth Mark E.,Sethupathy Praveen

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Hepatology

Link

https://www.nature.com/articles/s41575-022-00580-3.pdf

Reference166 articles.

1. Edmondson, H. A. Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. AMA J. Dis. Child. 91, 168–186 (1956).

2. Berman, M. M., Libbey, N. P. & Foster, J. H. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma–an atypical variant with a favorable prognosis. Cancer 46, 1448–1455 (1980).

3. Craig, J. R., Peters, R. L., Edmondson, H. A. & Omata, M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 46, 372–379 (1980). This paper names fibrolamellar carcinoma and describes the tumour as a distinct entity.

4. Farhi, D. C., Shikes, R. H. & Silverberg, S. G. Ultrastructure of fibrolamellar oncocytic hepatoma. Cancer 50, 702–709 (1982).

5. O’Neill, A. F. et al. Fibrolamellar carcinoma: an entity all its own. Curr. Probl. Cancer 45, 100770 (2021). A current review that emphasizes clinical aspects of FLC.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma;Liver Cancer;2024-08-08

2. Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma;Cell Reports Medicine;2024-08

3. An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer;Hepatology Communications;2024-05-10

4. DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma;PLOS Genetics;2024-03-21

5. DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma;Cell Reports Medicine;2024-03